Smarter oncology second opinion — AI-powered, expert-reviewed, using your existing NGS report.
Read More
Company
Our TechnologyOur StoryOur TeamCareersContact Us
Solutions
For OncologistsFor Partners
Resources
All ResourcesNewsMedia CoveragePublicationsOpinionsEnhancing NGS
Get a Second Opinion
Terms of Use | Cookie Policy | Privacy Policy
All Resources
Publications
Events
Media Coverage
News
Press ReleasesPartnershipsArticlesOpinionsEnhancing NGS
Get a Second Opinion
Close Cookie Popup
We use cookies
We use cookies to enhance your browsing experience, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Learn more in our Cookie Policy.
Accept All Cookies
Reject All
Preferences
Close Cookie Preference Manager
Cookie settings
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Accept All Cookies
Save preferences
Made by Flinch 77
Oops! Something went wrong while submitting the form.
Cookies Preferences
June 10, 2026
Back to Media Coverage

Many Cancer Patients Leave Treatment Options on the Table - You Don’t Have To

June 10, 2026

Genomate Health today launched its physician-led, AI-powered second opinion service, available via telehealth and eligible for HSA/FSA reimbursement. Genomate’s AI builds a personalized model of each patient’s tumor, informing medical experts of optimal treatment options, so that patients never have to wonder whether something important was missed.

Other Media Coverage

See all
Webinar: Matching Patients with Treatments
July 17, 2024
Read Article
How Vietnam is Leveraging AI to Reshape Healthcare
December 1, 2024
Read Article
Genomate Health Raises $2M, Enters US Market With Precision Oncology Clinical Decision Support Tool
May 14, 2025
Read Article

Other Resources

Events
Publications
Browse All
News
Back to Top
Award banner - genomeweb, best place to work 2025
Company
About Genomate®
Our Story
Our Team
Oncompas Medicine
Careers
Contact
Solutions
For Oncologists
For Partners
Order a Report
Services
For Patients
Order a Second Opinion
Resources
Browse
Publications
News
Events
Opinions
Enhancing NGS
Precision Care Pledge
The Genomate® Report can be used and clinically interpreted only by physicians or other qualified healthcare professionals. Genomate® is a clinical decision support software and is not intended to diagnose, treat, cure, prevent, or mitigate any condition. None of the statements contained herein have been evaluated by the U.S. Food and Drug Administration. Learn more.